Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

                    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant                           ( print page 26490)                        applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Member Conflict: Medical Imaging Investigations.                    

*Date:*                         June 29, 2018.                    

*Time:*                         1:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Songtao Liu, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5118, Bethesda, MD 20817, 301-827-6828,                         *songtao.liu@nih.gov*.                    

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Small Business: Dermatology, Rheumatology and Inflammation.                    

*Date:*                         July 6, 2018.                    

*Time:*                         8:00 a.m. to 12:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt at Olive 8, 1635 8th Avenue, Seattle, WA 98275.                    

*Contact Person:*                         Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301-435-1212,                         *kumarra@csr.nih.gov*.                    

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Role of Microbiome in the Developmental Origins of Health and Disease.                    

*Date:*                         July 6, 2018.                    

*Time:*                         8:00 a.m. to 6:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Embassy Suites by Hilton Washington DC Chevy Chase, Embassy Suites by Hilton Washington DC Chevy Chase, 4300 Military Road, Washington, DC 20015.                    

*Contact Person:*                         Meenakshisundar Ananthanarayanan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2178, Bethesda, MD 20892, 301-827-6281,                         *meena.ananthanarayanan@nih.gov*.                    

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; PAR16-274/275: Serious Adverse Drug Reaction Research.                    

*Date:*                         July 6, 2018.                    

*Time:*                         10:00 a.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Alexander D Politis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 20892, (301) 435-1150,                         *politisa@csr.nih.gov*.                    

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Member Conflict: Dermatology and Autoimmune Diseases.                    

*Date:*                         July 6, 2018.                    

*Time:*                         1:00 p.m. to 5:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt at Olive 8, 1635 8th Avenue, Seattle, WA 98275.                     

*Contact Person:*                         Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301-435-1212,                         *kumarra@csr.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: June 1, 2018.

Sylvia L. Neal,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2018-12174 Filed 6-6-18; 8:45 am]

BILLING CODE 4140-01-P